Vireo Growth (VREOF) Tax Provisions (2020 - 2026)
Vireo Growth (VREOF) posted Tax Provisions of $18.3 million for Q1 2026, down 15.8% sequentially from $21.7 million in Q4 2025, and up 976.47% YoY from $1.7 million in Q1 2025.
Vireo Growth (VREOF) Tax Provisions (2020 - 2026) Analysis & Trends
Vireo Growth has reported Tax Provisions for 7 years, with the latest figure at $18.3 million in Q1 2026.
- Quarterly Tax Provisions rose 976.47% year-over-year to $18.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.2 million (up 556.68% YoY) and the FY2025 annual result came in at $41.6 million, up 274.42% from the prior year.
- Tax Provisions fell to $18.3 million in Q1 2026 per VREOF's latest filing, from $21.7 million in the prior quarter.
- Over five years, Tax Provisions peaked at $21.7 million in Q4 2025 and troughed at -$1.3 million in Q4 2023.
- A 5-year average of $4.9 million and a median of $2.0 million in 2022 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2023 and 2025: Tax Provisions plunged 167.61% in 2023, then jumped 1003.18% in 2025.
- Over 5 years, Tax Provisions stood at $2.0 million in 2022, then slumped by 167.61% to -$1.3 million in 2023, then soared by 428.55% to $4.3 million in 2024, then surged by 400.41% to $21.7 million in 2025, then dropped by 15.8% to $18.3 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $18.3 million, $21.7 million, and $13.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Vireo Growth | 493.25 Mn | 350.95 Mn | 95.30 Mn | 20.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.30 Mn |
| Dec 31, 2025 | 21.73 Mn |
| Sep 30, 2025 | 13.35 Mn |
| Jun 30, 2025 | 4.85 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | 4.34 Mn |
| Sep 30, 2024 | 2.39 Mn |
| Jun 30, 2024 | 440,000.00 |
| Mar 31, 2024 | 3.95 Mn |
| Dec 31, 2023 | -1.32 Mn |
| Sep 30, 2023 | 3.98 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | 1.96 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 965,000.00 |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 2.31 Mn |
| Sep 30, 2021 | 530,000.00 |
| Jun 30, 2021 | 885,000.00 |